Chemoinformaics analysis of 6alpha-Acetoxyazadirone
| Molecular Weight | 494.628 | nRot | 3 |
| Heavy Atom Molecular Weight | 456.324 | nRig | 28 |
| Exact Molecular Weight | 494.267 | nRing | 5 |
| Solubility: LogS | -4.703 | nHRing | 1 |
| Solubility: LogP | 3.796 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 5 |
| nHA | 6 | APOL | 80.2501 |
| nHD | 0 | BPOL | 45.9339 |
| QED | 0.391 |
| Synth | 5.056 |
| Natural Product Likeliness | 3.291 |
| NR-PPAR-gamma | 0.078 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -5.081 |
| MDCK | 0.0000311 |
| BBB | 0.089 |
| PPB | 0.918467 |
| VDSS | 2.65 |
| FU | 0.0723313 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.085 |
| CYP2c19-inh | 0.252 |
| CYP2c19-sub | 0.599 |
| CYP2c9-inh | 0.613 |
| CYP2c9-sub | 0.046 |
| CYP2d6-inh | 0.772 |
| CYP2d6-sub | 0.06 |
| CYP3a4-inh | 0.894 |
| CYP3a4-sub | 0.624 |
| CL | 2.892 |
| T12 | 0.448 |
| hERG | 0.501 |
| Ames | 0.008 |
| ROA | 0.968 |
| SkinSen | 0.104 |
| Carcinogencity | 0.083 |
| EI | 0.015 |
| Respiratory | 0.978 |
| NR-Aromatase | 0.575 |
| Antiviral | Yes |
| Prediction | 0.808553 |